These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15064093)

  • 21. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boldine action against the stannous chloride effect.
    Reiniger IW; Ribeiro da Silva C; Felzenszwalb I; de Mattos JC; de Oliveira JF; da Silva Dantas FJ; Bezerra RJ; Caldeira-de-Araújo A; Bernardo-Filho M
    J Ethnopharmacol; 1999 Dec; 68(1-3):345-8. PubMed ID: 10624900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein.
    Cui Y; Narasimhulu CA; Liu L; Zhang Q; Liu PZ; Li X; Xiao Y; Zhang J; Hao H; Xie X; He G; Cui L; Parthasarathy S; Liu Z
    Sci Rep; 2015 Nov; 5():16339. PubMed ID: 26536834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Boldine Activity against Intracellular Amastigotes of
    Salama IC; Arrais-Lima C; Arrais-Silva WW
    Korean J Parasitol; 2017 Jun; 55(3):337-340. PubMed ID: 28719960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a dietary oxidized fat on cholesterol in plasma and lipoproteins and the susceptibility of low-density lipoproteins to lipid peroxidation in guinea pigs fed diets with different concentrations of vitamins E and C.
    Eder K; Keller U; Brandsch C
    Int J Vitam Nutr Res; 2004 Jan; 74(1):11-20. PubMed ID: 15060896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
    Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
    Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M; Dornfeld L; Kaplan M; Coleman R; Gaitini D; Nitecki S; Hofman A; Rosenblat M; Volkova N; Presser D; Attias J; Hayek T; Fuhrman B
    Drugs Exp Clin Res; 2002; 28(2-3):49-62. PubMed ID: 12224378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B; Volkova N; Rosenblat M; Aviram M
    Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boldo and boldine: an emerging case of natural drug development.
    Speisky H; Cassels BK
    Pharmacol Res; 1994; 29(1):1-12. PubMed ID: 8202440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.
    Sparrow CP; Doebber TW; Olszewski J; Wu MS; Ventre J; Stevens KA; Chao YS
    J Clin Invest; 1992 Jun; 89(6):1885-91. PubMed ID: 1601995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of magnoflorine isolated from coptidis rhizoma on Cu2+-induced oxidation of human low density lipoprotein.
    Hung TM; Na M; Min BS; Zhang X; Lee I; Ngoc TM; Thuong PT; Sok DE; Bae K
    Planta Med; 2007 Oct; 73(12):1281-4. PubMed ID: 17973202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The aporphine alkaloid boldine improves endothelial function in spontaneously hypertensive rats.
    Lau YS; Machha A; Achike FI; Murugan D; Mustafa MR
    Exp Biol Med (Maywood); 2012 Jan; 237(1):93-8. PubMed ID: 22156043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidants and atherosclerosis.
    Niki E
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):156-9. PubMed ID: 14748738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression.
    Tailleux A; Gozzo A; Torpier G; Martin-Nizard F; Bonnefont-Rousselot D; Lemdani M; Furman C; Foricher R; Chevé G; Yous S; Micard F; Bordet R; Gardes-Albert M; Lesieur D; Teissier E; Fruchart JC; Fiévet C; Duriez P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):241-9. PubMed ID: 16116326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cranberry flavonoids, atherosclerosis and cardiovascular health.
    Reed J
    Crit Rev Food Sci Nutr; 2002; 42(3 Suppl):301-16. PubMed ID: 12058989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase Inhibition by a New Synthetic Derivative of the Aporphine Alkaloid Boldine.
    Kazemi Noureini S; Kheirabadi M; Masoumi F; Khosrogerdi F; Zarei Y; Suárez-Rozas C; Salas-Norambuena J; Kennedy Cassels B
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory and antipyretic effects of boldine.
    Backhouse N; Delporte C; Givernau M; Cassels BK; Valenzuela A; Speisky H
    Agents Actions; 1994 Oct; 42(3-4):114-7. PubMed ID: 7879695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.
    Hamilton CA
    Pharmacol Ther; 1997; 74(1):55-72. PubMed ID: 9336016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.